相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Prevalence, Clinicopathologic Associations, and Molecular Spectrum of ERBB2 (HER2) Tyrosine Kinase Mutations in Lung Adenocarcinomas
Maria E. Arcila et al.
CLINICAL CANCER RESEARCH (2012)
Lung Adenocarcinomas with HER2-Activating Mutations Are Associated with Distinct Clinical Features and HER2/EGFR Copy Number Gains
Chenguang Li et al.
JOURNAL OF THORACIC ONCOLOGY (2012)
Characteristics of lung cancer in women: Importance of hormonal and growth factors
Isabelle Rouquette et al.
LUNG CANCER (2012)
Clinical activity of afatinib (BIBW 2992) in patients with lung adenocarcinoma with mutations in the kinase domain of HER2/neu
J. De Greve et al.
LUNG CANCER (2012)
Chipping away at the lung cancer genome
William Pao et al.
NATURE MEDICINE (2012)
Treatment of HER2-positive breast cancer: current status and future perspectives
Carlos L. Arteaga et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2012)
International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
William D. Travis et al.
JOURNAL OF THORACIC ONCOLOGY (2011)
Prognostic and predictive implications of HER2/ERBB2/neu gene mutations in lung cancers
Kenji Tomizawa et al.
LUNG CANCER (2011)
Randomized Phase II Multicenter Trial of Two Schedules of Lapatinib as First- or Second-Line Monotherapy in Patients with Advanced or Metastatic Non-Small Cell Lung Cancer
Helen J. Ross et al.
CLINICAL CANCER RESEARCH (2010)
The Role of Human Epidermal Growth Factor Receptor 2 as a Prognostic Factor in Lung Cancer A Meta-Analysis of Published Data
Lingxiang Liu et al.
JOURNAL OF THORACIC ONCOLOGY (2010)
Understanding the Mechanisms Behind Trastuzumab Therapy for Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer
Neil L. Spector et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
HER2YVMA drives rapid development of adenosquamous lung tumors in mice that are sensitive to BIBW2992 and rapamycin combination therapy
Samanthi A. Perera et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
The IASLC lung cancer staging project: Proposals for the revision of he TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours
Peter Goldstraw et al.
JOURNAL OF THORACIC ONCOLOGY (2007)
Mutational analysis of the HER2 gene in lung tumors from Caucasian patients:: Mutations are mainly present in adenocarcinomas with bronchioloalveolar features
Fiamma Buttitta et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Non-small-cell lung cancer and Ba/F3 transformed cells harboring the ERBB2 G776insV_G/C mutation are sensitive to the dual-specific epidermal growth factor receptor and ERBB2 inhibitor HKI-272
Takeshi Shimamura et al.
CANCER RESEARCH (2006)
HER2 mutation and response to trastuzumab therapy in non-small-cell lung cancer
F Cappuzzo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Somatic mutations of the HER2 kinase domain in lung adenocarcinomas
H Shigematsu et al.
CANCER RESEARCH (2005)
Intragenic ERBB2 kinase mutations in tumours
P Stephens et al.
NATURE (2004)
Randomized phase II trial of gemcitabine-cisplatin with or without trastuzumab in HER2-positive non-small-cell lung cancer
U Gatzemeier et al.
ANNALS OF ONCOLOGY (2004)
分享论文
